Urocortin III (Human)


Catalog #
019-28 100 µg $180

Sequence:  ()
  • Molecular Weight:
  • 4137.92
  • Purity:
  • ≥ 95%
  • Validation:
  • Exhibits correct molecular weight
  • Solubility:
  • Insoluble in water.
    Dissolve in 100-200 µl of DMSO. Then dilute with water or any desired buffer.
  • Storage:
  • Up to 6 months in lyophilized form at 0-5°C.
    For best results, rehydrate just before use.
    After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
  • Appearance:
  • White powder
  • Contents:
  • Each vial contains 100 µg of NET peptide.

Plasma urocortin levels in the diagnosis of ovarian endometriosis.
Florio P, Reis FM, Torres PB, et al. Obstet Gynecol. 2007;110(3):594-600.

High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
Florio P, Torricelli M, De falco G, et al. J Hypertens. 2006;24(9):1831-40.

Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies.
Torricelli M, Ignacchiti E, Giovannelli A, et al. Eur J Endocrinol. 2006;154(2):281-5.

Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
Takahashi K, Totsune K, Saruta M, et al. Peptides. 2006;27(1):178-82.

High fetal urocortin levels at term and preterm labor.
Florio P, Torricelli M, Galleri L, et al. J Clin Endocrinol Metab. 2005;90(9):5361-5.

Urocortin 3/stresscopin in human colon: possible modulators of gastrointestinal function during stressful conditions.
Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H. Peptides. 2005;26(7):1196-206.

Expression of urocortin III/stresscopin in human heart and kidney.
Takahashi K, Totsune K, Murakami O, et al. J Clin Endocrinol Metab. 2004;89(4):1897-903.

Urocortin 1 in colonic mucosa in patients with ulcerative colitis.
Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H. J Clin Endocrinol Metab. 2004;89(11):5352-61.

Differential interactions of urocortin/corticotropin-releasing hormone peptides with the blood-brain barrier.
Kastin AJ, Akerstrom V. Neuroendocrinology. 2002;75(6):367-74.

Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells.
Aggelidou E, Hillhouse EW, Grammatopoulos DK. Proc Natl Acad Sci USA. 2002;99(5):3300-5.

Related Products

Catalog# Product Size Price Buy Now